Company Search:
Advanced Search
Sponsored Links
Halozyme Therapeutics, Inc. Company Snapshot
Halozyme Therapeutics, Inc. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Halozyme Therapeutics with three other companies in this sector in the United States: ANI Pharmaceuticals Inc (2016 sales of $128.62 million of which 100% was Pharmaceutical Products), Momenta Pharmaceuticals, Inc. ($109.62 million of which 100% was Drug Products), and Heska Corporation ($130.08 million of which 83% was Core Companion Animal Health).

Sales Analysis. During the year ended December of 2016, sales at Halozyme Therapeutics were $146.69 million. This is an increase of 8.6% versus 2015, when the company's sales were $135.06 million. This was the fourth straight year of sales growth at Halozyme Therapeutics.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Halozyme Therapeutics, Inc.
  Stock Performance Chart for Halozyme Therapeutics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 17.98
(Figures in U.S. Dollars)
1 Week -11.7%   13 Weeks -10.5%  
4 Weeks 0.9%   52 Weeks 56.3%  
Halozyme Therapeutics, Inc. Key Data:
  Ticker: HALO Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 146,691,000
(Year Ending Jan 2017).
Employees: 153
  Currency: U.S. Dollars Market Cap: 2,558,571,980
  Fiscal Yr Ends: December Shares Outstanding: 142,301,000
  Share Type: Common Closely Held Shares: 18,978,853
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.